HK1222325A1 - 高效的胰酶藥物組合物 - Google Patents

高效的胰酶藥物組合物 Download PDF

Info

Publication number
HK1222325A1
HK1222325A1 HK16110490.6A HK16110490A HK1222325A1 HK 1222325 A1 HK1222325 A1 HK 1222325A1 HK 16110490 A HK16110490 A HK 16110490A HK 1222325 A1 HK1222325 A1 HK 1222325A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical compositions
high potency
pancreatin
pancreatin pharmaceutical
compositions
Prior art date
Application number
HK16110490.6A
Other languages
English (en)
Chinese (zh)
Inventor
羅伯特‧貝克爾
Stephen Perrett
路易吉‧波爾特里
罗伯特‧贝克尔
路易吉‧吉多斯
路易吉‧波尔特里
保拉‧阿爾祖菲
溫琴扎
保拉‧阿尔祖菲
皮隆蒂
温琴扎.皮隆蒂
Michael Tota
William W. Ward
Original Assignee
阿普塔利斯制药有限公司
Stephen Perrett
罗伯特．贝克尔
路易吉．波尔特里
路易吉．吉多斯
保拉．阿尔祖菲
温琴扎.皮隆蒂
Michael Tota
William W. Ward
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53042009&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1222325(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 阿普塔利斯制药有限公司, Stephen Perrett, 罗伯特．贝克尔, 路易吉．波尔特里, 路易吉．吉多斯, 保拉．阿尔祖菲, 温琴扎.皮隆蒂, Michael Tota, William W. Ward filed Critical 阿普塔利斯制药有限公司
Publication of HK1222325A1 publication Critical patent/HK1222325A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/94—Pancreatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK16110490.6A 2013-11-05 2014-11-05 高效的胰酶藥物組合物 HK1222325A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361900092P 2013-11-05 2013-11-05
US201361900092P 2013-11-05
PCT/US2014/063984 WO2015069677A1 (en) 2013-11-05 2014-11-05 High potency pancreatin pharmaceutical compositions

Publications (1)

Publication Number Publication Date
HK1222325A1 true HK1222325A1 (zh) 2017-06-30

Family

ID=53042009

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16110490.6A HK1222325A1 (zh) 2013-11-05 2014-11-05 高效的胰酶藥物組合物

Country Status (13)

Country Link
EP (2) EP3613429A1 (enExample)
JP (1) JP2017500885A (enExample)
KR (1) KR20170052520A (enExample)
CN (1) CN106659773A (enExample)
AU (1) AU2014346930A1 (enExample)
BR (1) BR112016000658A2 (enExample)
CA (1) CA2915671A1 (enExample)
ES (1) ES2834483T3 (enExample)
HK (1) HK1222325A1 (enExample)
IL (3) IL243435B (enExample)
MX (1) MX2016000480A (enExample)
RU (1) RU2015155470A (enExample)
WO (1) WO2015069677A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1319655B1 (it) 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
EP2079445B1 (en) 2007-02-20 2015-11-04 Aptalis Pharma Limited Stable digestive enzyme compositions
WO2009109856A2 (en) 2008-03-07 2009-09-11 Axcan Pharma Inc. Method for detecting infectious parvovirus in pharmaceutical preparations
EP2621476B8 (en) 2010-10-01 2020-12-23 Société des Produits Nestlé S.A. Enteric coated, low-strength pancrelipase formulations
RU2602183C2 (ru) 2011-08-08 2016-11-10 Апталис Фарма Лтд. Способ проведения теста на растворение твердых композиций, содержащих пищеварительные ферменты
US10184121B2 (en) 2013-06-28 2019-01-22 Allergan Pharmaceuticals International Limited Methods for removing viral contaminants from pancreatic extracts
ES2743212T5 (es) 2013-07-22 2023-04-25 Allergan Pharmaceuticals Int Ltd Métodos para preparar pancreatina
WO2015020943A2 (en) 2013-08-09 2015-02-12 Aptalis Pharma Ltd. Digestive enzyme composition suitable for enteral administration

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2751330A (en) * 1952-08-27 1956-06-19 Armour & Co Use of a salt in the extraction slurry in recovering proteolytic enzymes from pancreas gland material
GB928654A (en) 1960-10-25 1963-06-12 Philips Nv Improvements in or relating to the production of pancreatin
US3168448A (en) 1963-01-07 1965-02-02 Wilson & Co Inc Process of preparing a lipolytic enzyme composition
DE2460334C3 (de) * 1974-12-20 1979-09-06 Hoechst Ag, 6000 Frankfurt Verfahren zur Gewinnung von Insulin und Pankreatin aus Schweinepankreas
DE3377506D1 (en) * 1982-12-30 1988-09-01 Nordmark Arzneimittel Gmbh Process for obtaining pancreatin
FR2603804B1 (fr) * 1986-09-17 1989-10-27 Jouveinal Sa Lipases et extraits lipasiques, leur procede de preparation et leur application en therapeutique
DE3927286C2 (de) * 1989-08-18 1997-07-24 Roehm Gmbh Wäßrige Enzym-Flüssigformulierungen
US6051220A (en) 1995-05-31 2000-04-18 Medzyme N.V. And Simon Lodewijk Scharpe Composition to improve digestibility and utilization of nutrients
US5750104A (en) * 1996-05-29 1998-05-12 Digestive Care Inc. High buffer-containing enteric coating digestive enzyme bile acid compositions and method of treating digestive disorders therewith
DE19724845A1 (de) * 1996-08-28 1998-03-05 Solvay Pharm Gmbh Verwendung von komplexen Lipiden als stabilisierende Zusätze zu pharmazeutischen Zubereitungen von Verdauungsenzymgemischen
US20010046493A1 (en) 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
AR032392A1 (es) * 2001-01-19 2003-11-05 Solvay Pharm Gmbh Mezcla de enzimas, preparado farmaceutico y utilizacion de dicho preparado.
CA2419572A1 (en) * 2003-02-18 2004-08-18 Axcan Pharma Inc. High dosage protease formulation
US20060198838A1 (en) * 2004-09-28 2006-09-07 Fallon Joan M Combination enzyme for cystic fibrosis
HUE031245T2 (en) 2004-10-14 2017-06-28 Lilly Co Eli Preparations containing lipase, protease and amylase for the treatment of pancreatic insufficiency
MX2008000850A (es) 2005-07-29 2008-03-18 Solvay Pharm Gmbh Procedimientos para la fabricacion de polvo de pancreatina esterilizada.
EP2079445B1 (en) * 2007-02-20 2015-11-04 Aptalis Pharma Limited Stable digestive enzyme compositions
SG184095A1 (en) * 2010-03-19 2012-10-30 Aptalis Pharma Canada Inc Gastro-resistant enzyme pharmaceutical compositions
JP2013525488A (ja) * 2010-05-03 2013-06-20 アプタリス ファーマ リミテッド 消化酵素混合物を含有するパンクレアチンを含むマイクロペレット組成物
EP2621476B8 (en) * 2010-10-01 2020-12-23 Société des Produits Nestlé S.A. Enteric coated, low-strength pancrelipase formulations
CN103060297B (zh) * 2012-12-28 2014-06-25 青岛九龙生物医药有限公司 一种分离纯化胰蛋白酶的方法
CN103060296B (zh) * 2012-12-30 2014-05-21 青岛九龙生物医药有限公司 从动物胰脏中提取胰蛋白酶的方法
ES2743212T5 (es) * 2013-07-22 2023-04-25 Allergan Pharmaceuticals Int Ltd Métodos para preparar pancreatina

Also Published As

Publication number Publication date
BR112016000658A2 (pt) 2018-03-20
JP2017500885A (ja) 2017-01-12
MX2016000480A (es) 2016-10-21
EP3613429A1 (en) 2020-02-26
IL274583B (en) 2022-06-01
CA2915671A1 (en) 2015-05-14
IL274583A (en) 2020-06-30
IL243435B (en) 2020-06-30
IL243435A0 (en) 2016-03-31
EP3003360A4 (en) 2017-04-26
EP3003360A1 (en) 2016-04-13
CN106659773A (zh) 2017-05-10
WO2015069677A1 (en) 2015-05-14
KR20170052520A (ko) 2017-05-12
EP3003360B1 (en) 2020-10-07
ES2834483T3 (es) 2021-06-17
RU2015155470A3 (enExample) 2018-09-10
AU2014346930A1 (en) 2016-01-07
RU2015155470A (ru) 2017-08-21
IL284419A (en) 2021-07-29

Similar Documents

Publication Publication Date Title
WO2015019198A3 (en) High potency pancreatin pharmaceutical compositions
HK1222325A1 (zh) 高效的胰酶藥物組合物
WO2014153346A8 (en) Engineering a heterogeneous tissue from pluripotent stem cells
IN2015KN00262A (enExample)
MX365294B (es) Inhibidores de proteína cinasa dependiente de adn.
MX2020009780A (es) Compuestos de inhibidor de autotaxina.
WO2015085318A3 (en) Targeted adaptive vaccines
MX2016008448A (es) Conjugados de var2csa-farmaco.
MX2019000536A (es) Nuevas pirimidinas carboxamidas como inhibidores de enzima vanina-1.
SG10201804817TA (en) Delayed release compositions of linaclotide
PH12014501967A1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
MY195343A (en) A Novel Phtalazinone Derivatives and Manufacturing Process Thereof
PH12017501095A1 (en) Piperidine derivatives as hdac1/2 inhibitors
MX2016008130A (es) Derivados de piperidina con actividad multimodal contra el dolor.
WO2014121764A3 (en) 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions
MX2016006604A (es) Derivados de piperidina con actividad multimodal contra el dolor.
GB2497453A (en) Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV
TN2016000107A1 (en) Substituted phenylalanine derivatives
MX2015000179A (es) Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas.
MX2016005545A (es) Analogo de la relaxina humana, composicion farmaceutica del mismo y aplicacion farmaceutica del mismo.
MX2015003034A (es) Jeringa que contiene una composicion, en particular farmaceutica, que comprende inmunoglobulinas, su metodo de fabricacion y uso.
MX2013013436A (es) Derivados de indol sustituidos para el tratamiento de transtornos inmunologicos.
MX2015016603A (es) Composiciones de corticosteroides.
HK1212978A1 (zh) 芥子酸的新型衍生物
WO2016069542A3 (en) Lactone compounds and methods of making and using same